Can serum NGAL levels be used as an inflammation marker on hemodialysis patients with permanent catheter?

References

• Lascon E Jr, Lazarus JM, Himmelfarb J, Ikizler TA, Hakim RM. Balancing fistula first with catheters last. Am J Kidney Dis. 2007;50:379–395
   PubMedGoogle Scholar
• Stenvinkel P. The role of inflammation in the anaemia of end-stage renal disease. Nephrol Dial Transplant. 2001;16(7):36–40
   PubMedGoogle Scholar
• Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link? Kidney Int. 2001;59:407–414
   PubMed Web of Science ®Google Scholar
• Paul JL. Influence of uremia on polymorphonuclear leukocytes oxidative metabolism in end-stage renal disease and dialyzed patients. Nephron. 1991;57:428–432
   PubMedGoogle Scholar
• Cowland JB, Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil geletinase-associated lipocalin from humans. Genomics. 1997;45:17–23
   PubMed Web of Science ®Google Scholar
• Bolignano D, Coppolino G, Lacquaniti A, Buemi M. From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. Eur J Clin Invest. 2010;40(3):273–276
   PubMed Web of Science ®Google Scholar
• Bolignano D, Donato V, Lacquaniti A, et al. Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: A new protein enters the scene. Cancer Lett. 2010;288:10–16
   PubMed Web of Science ®Google Scholar
• Bolignano D, Donato V, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis. 2008;52:595–605
   PubMed Web of Science ®Google Scholar
• Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res. 2009;32:91–98
   PubMed Web of Science ®Google Scholar
• Bolignano D, Coppolino G, Campo S, et al. Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. Am J Nephrol. 2007;27:373–378
   PubMed Web of Science ®Google Scholar
• Bolignano D, Coppolino G, Lacquaniti A, Nicocia G, Buemi M. Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macro-proteinuric patients with worsening renal function. Kidney Blood Press Res. 2008;31:274–279
   PubMed Web of Science ®Google Scholar
• Malyszko J, Malyszko JS, Kozminski P, Koc-Zorawska E, Mysliwiec M, MacDougall I. Possible relationship between neutrophil gelatinase-associated lipocalin, hepcidin, and inflammation in hemodialyzed patients. Nephron Clin Pract. 2010;115:c268–c275
   PubMed Web of Science ®Google Scholar
• Nascimento MM, Pecoits-Filho R, Qureshi AR, et al. The prognostic impact of fluctuating levels of C-reaktif protein in Brazilian hemodialysis patient: A prospective study. Nephrol Dial Transplant. 2004;19:2803–2809
   PubMed Web of Science ®Google Scholar
• Den Elzen WP, van Manen JG, Boeschoten EW, Krediet RT, Dekker FW. The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysis. Nephrol Dial Transplant. 2006;21:1588–1595
   PubMedGoogle Scholar
• Bologa RM, Levine DM, Parker TS, et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis. 1998;32:107–114
   PubMed Web of Science ®Google Scholar
• Malaponte G, Bevelacqua V, Fatuzzo P, et al. IL-1beta, TNF-alpha and IL-6 release from monocytes in hemodialysis patients in relation to dialytic age. Nephrol Dial Transplant. 2002;17:1964–1970
   PubMed Web of Science ®Google Scholar
• Sachdeva M, Kovalchuk O, Bitzer M, Mokrzycki MH. Vascular access type and changes in inflammatory markers in incident dialysis patients: A pilot study. J Vasc Access. 2009;10:174–179
   PubMedGoogle Scholar
• Movilli E, Brunori G, Camerini C, et al. The kind of vascular access influences the baseline inflammatory status and epoetin response in chronic hemodialysis patients. Blood Purif. 2006;24:387–393
   PubMedGoogle Scholar
• Karlsen JR, Borregaard N, Cowland JB. Induction of neutrophil gelatinase-associated lipocalin expression by co-stimulation with interleukin-17 and tumor necrosis factor-alpha is controlled by IkappaB-zeta but neither by C/EBP-beta nor C/EBP-delta. J Biol Chem. 2010;285(19):14088–14100
   PubMedGoogle Scholar
• Arena A, Stassi G, Iannello D, et al. Both IL-1β and TNF-α regulate NGAL expression in polymorphonuclear granulocytes of chronic hemodialysis patients. Mediators Inflamm. 2010;2010:61337–61344
   Google Scholar
• Malyszko J, Malyszko JS, Koc-Zorawska E, Kozminski P, Mysliwiec M. Neutrophil gelatinase-associated lipocalin in dialyzed patients is related to residual renal function, type of renal replacement therapy and inflammation. Kidney Blood Press Res. 2009;32:464–469
   Google Scholar
• Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:337–344
   Google Scholar
• Roudkenar MH, Halabian R, Roushandeh AM, et al. Lipocalin 2 regulation by thermal stresses: Protective role of Lcn2/NGAL against cold and heat stresses. Exp Cell Res. 2009;315(18):3140–3151
   Google Scholar
• Liu Q, Nilsen-Hamilton M. Identification of a new acute phase protein. J Biol Chem. 1995;270: 22565–22570
   Google Scholar
• Jonsson P, Stahl ML, Ohlsson K. Extracorporeal circulation causes release of neutrophil gelatinase-associated lipocalin (NGAL). Mediators Inflamm. 1999;8:169–171
   Google Scholar
• Hörl WH. Hemodialysis membranes: Interleukins, biocompatibility, and middle molecules. J Am Soc Nephrol. 2002;13:62–71
   Google Scholar
• Mitsnefes MM, Kathman TS, Mishra J, et al. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol. 2007;22(1):101–108
   Google Scholar
• Taskapan H, Taskapan MC, Orman I, et al. NGAL and NT-proBNP levels in diabetic patients with macroproteinuria. Ren Fail. 2013;35(9):1273–1277
   Google Scholar
• Martí J, Fuster J, Solà AM, et al. Prognostic value of serum neutrophil gelatinase-associated lipocalin in metastatic and nonmetastatic colorectal cancer. World J Surg. 2013;37(5):1103–1109
   Google Scholar
• Tomczak J, Wasilewska A, Milewski R. Urine NGAL and KIM-1 in children and adolescents with hyperuricemia. Pediatr Nephrol. 2013;28(9):1863–1869
   Google Scholar
• Lowrie EG, Lew NL. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis. 1990;15:458–482
   Google Scholar
• Tsai YC, Lee CT, Huang TL, et al. Inflammatory marker but not adipokine predicts mortality among long-term hemodialysis patients. Mediators Inflamm. 2007;2007:19891–19898
   Google Scholar